WebApr 11, 2024 · Let’s start up with the current stock price of Dyne Therapeutics Inc. (DYN), which is $8.82 to be very precise. The Stock rose vividly during the last session to $9.35 … WebApr 6, 2024 · 91,5%. More Financials. Company. Dyne Therapeutics Inc. is a muscle disease company. The Company is focused on advancing therapeutics for patients with genetically driven diseases. It is utilizing its FORCE platform to overcome the limitations of muscle tissue delivery and oligonucleotide therapeutics for muscle diseases.
Dyne Therapeutics, Inc. (DYN) Latest Stock News & Headlines
WebJan 26, 2024 · Dyne Therapeutics (DYN) reached the highest level since September as Guggenheim launched its coverage with a Buy rating citing its potential in muscular … WebView the latest Dyne Therapeutics Inc. (DYN) stock price, news, historical charts, analyst ratings and financial information from WSJ. greek organizations crafts
Dyne Therapeutics, Inc. (NASDAQ:DYN) Receives …
WebApr 11, 2024 · Dyne Therapeutics Stock Performance. NASDAQ DYN opened at $8.82 on Tuesday. The stock has a market cap of $496.90 million, a price-to-earnings ratio of -2.72 and a beta of 0.24. The business has a 50 day simple moving average of $12.59 and a 200 day simple moving average of $12.09. Dyne Therapeutics has a 52-week low of $4.30 … WebDyne Therapeutics to Present at Upcoming Investor Conferences. WALTHAM, Mass., March 07, 2024 (GLOBE NEWSWIRE) -- Dyne Therapeutics, Inc. (Nasdaq: DYN), a clinical-stage muscle disease company focused on advancing innovative life-transforming therapeutics for people living with genetically driven diseases, today announced that … WebApr 11, 2024 · A high-level overview of Dyne Therapeutics, Inc. (DYN) stock. Stay up to date on the latest stock price, chart, news, analysis, fundamentals, trading and … greek origin names for boys